Common Cold

·MeSH: Common Cold

11 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Approved(11)

Drug	Company
dextromethorphan polistirex	Amneal Pharmaceuticals, Inc. (AMRX)
fexofenadine	DR REDDYS LABORATORIES LTD (RDY)
guaifenesin	DR REDDYS LABORATORIES LTD (RDY)
guaifenesin	PERRIGO Co plc (PRGO)
guaifenesin	Amneal Pharmaceuticals, Inc. (AMRX)
guaifenesin	SUNSET ISLAND GROUP (SUN)
ibuprofen	AERIE PHARMACEUTICALS INC (AERI)
ibuprofen	GT Biopharma, Inc. (GTBP)
ibuprofen	PATHEON N.V. (PTI)
ibuprofen	CHINA PHARMA HOLDINGS, INC. (CPHI)
sodium	Ginkgo Bioworks Holdings Inc. (DNA)

BioSniper tracks 11 drugs in development for Common Cold across 9 companies.

There are 1 clinical trial targeting Common Cold tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.